article thumbnail

Targeted alpha therapy’s ‘elite 8’ radionuclides

AuntMinnie

Ultimately, most hospitals conducting trials receive doses of these eight radionuclides from upstream radiopharmaceutical production facilities, with U.S. This next generation of radionuclides is showing promise in a broad range of cancers, she said.

article thumbnail

CMS proposes new coverage for PET imaging agents

AuntMinnie

Centers for Medicare and Medicaid Services (CMS) proposed a new reimbursement plan July 10 for diagnostic PET scans that would provide separate payments for radiopharmaceuticals, as well as an extra payment for hospitals when they use domestically produced technetium-99m (Tc-99m).

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

ARRS: How to manage the side effects of radiopharmaceuticals

AuntMinnie

Theranostics treatments are used with increasing frequency now since the approvals and expansions of Lutathera (lutetium-177 [Lu-177]) DOTATATE, a radiopharmaceutical for neuroendrocrine tumors (NETs) and Pluvicto, Lu-177 PSMA-617, for prostate cancer. In addition, dose calculations estimated mean dose to the arm of approximately 3 Gy.

article thumbnail

CMS seeks feedback on issuing separate payment for diagnostic radiopharmaceuticals

Radiology Business

The agency issued its solicitation as part of the 2024 Hospital Outpatient Prospective Payment System proposed rule, released late Thursday.

article thumbnail

IMV: PET scan volumes continue to grow

AuntMinnie

In terms of 2023 spending, the average radiopharmaceutical expenditure per fixed PET site is estimated to be $517,000. This could indicate that non-hospital sites may have a more specific focus on PET/CT exams, compared to a more broad integrative focus across nuclear medicine in hospital sites.

PET Scan 290
article thumbnail

The rise of theranostics: Part 5 -- Advice from center administrators

AuntMinnie

As nuclear medicine therapies gain stature compared to nuclear medicine in diagnostic imaging, hospital administrators may be eyeing the potential of adding theranostics services. Reshaping the hospital's nuclear medicine and radiopharmaceutical strategy toward theranostics involves intensive and inclusive planning, Beyder explained at SNMMI.

article thumbnail

GE HealthCare to launch Flyrcado injection in U.S.

AuntMinnie

Pass-through payment status will allow the CMS to provide separate payments for the radiopharmaceutical and the PET-CT scan when performed with Flyrcado in the hospital outpatient setting. Flyrcado will be unveiled at the ACC conference on March 29.